Widya Juwita
Widya Juwita has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Zakiyatul Faizah
Department of Medical Biology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
2 shared publications - Fachry Achmad Prodjokusumo
Andrology Study Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
1 shared publication - Faisal Yusuf Ashari
Andrology Clinic, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
1 shared publication - Khoirul Ima
Department of Anatomy, Military Medical Faculty, Indonesia Defense University, Bogor, Indonesia
1 shared publication - Petrus Supardi
Andrology Clinic, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
1 shared publication - Ria Margiana
Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 8 (2) , 138-143
In vitro Ubiquinone Supplementation Increased Postthaw Sperm Motility in Severe Oligozoospermia
Introduction: Severe oligozoospermia (in vitro ubiquinone supplementation on postthaw sperm motility and viability were examined in men with severe oligozoospermia. Methods: A posttest-only control-group design was used in this laboratory study, with eight semen samples exhibiting severe oligozoospermia. The samples were evenly allocated to control (no supplementation) and treatment (100 µM ubiquinone added to the cryopreservation solution) groups. Motile spermatozoa (10–15 cells/aliquot) were selected via micromanipulation, cryopreserved in Origio™ media, and kept for 24 h. Cell motility and viability postthaw were evaluated microscopically and analyzed using paired t -tests. Results: The postthaw motility of the ubiquinone-treated samples decreased significantly (88.93% ± 7.27%) compared to the control group (98.25% ± 4.95%; P = 0.032). The viability loss in the ubiquinone group (43.50% ± 7.74%) was insignificantly lower than in the control group (47.38% ± 10.47%) ( P = 0.357). Conclusions: In males with severe oligozoospermia, ubiquinone supplementation during cryopreservation decreased postthaw motility loss in sperm, indicating the possibility of employing ubiquinone as a targeted antioxidant adjunct for fertility preservation. However, given the settings of the research, ubiquinone’s impact on cell viability was restricted. To investigate the wider therapeutic uses of ubiquinone in fertility preservation, further research is needed.
- 1 July 2025
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 8 (2) , 138-143
Open AccessIn vitro Ubiquinone Supplementation Increased Postthaw Sperm Motility in Severe Oligozoospermia
Introduction: Severe oligozoospermia (in vitro ubiquinone supplementation on postthaw sperm motility and viability were examined in men with severe oligozoospermia. Methods: A posttest-only control-group design was used in this laboratory study, with eight semen samples exhibiting severe oligozoospermia. The samples were evenly allocated to control (no supplementation) and treatment (100 µM ubiquinone added to the cryopreservation solution) groups. Motile spermatozoa (10–15 cells/aliquot) were selected via micromanipulation, cryopreserved in Origio™ media, and kept for 24 h. Cell motility and viability postthaw were evaluated microscopically and analyzed using paired t -tests. Results: The postthaw motility of the ubiquinone-treated samples decreased significantly (88.93% ± 7.27%) compared to the control group (98.25% ± 4.95%; P = 0.032). The viability loss in the ubiquinone group (43.50% ± 7.74%) was insignificantly lower than in the control group (47.38% ± 10.47%) ( P = 0.357). Conclusions: In males with severe oligozoospermia, ubiquinone supplementation during cryopreservation decreased postthaw motility loss in sperm, indicating the possibility of employing ubiquinone as a targeted antioxidant adjunct for fertility preservation. However, given the settings of the research, ubiquinone’s impact on cell viability was restricted. To investigate the wider therapeutic uses of ubiquinone in fertility preservation, further research is needed.
- Open Access
- 31 August 2023
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 56 (4) , 421-427
Analyzing the factors that contribute to the development of embryological classical type of bladder exstrophy
Ria Margiana, Widya Juwita, Khoirul Ima, Zakiyatul Faizah, Supardi Supardi. Anat Cell Biol 2023;56:421-7. https://doi.org/10.5115/acb.23.056
- 31 August 2023
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 56 (4) , 421-427
Open AccessAnalyzing the factors that contribute to the development of embryological classical type of bladder exstrophy
Ria Margiana, Widya Juwita, Khoirul Ima, Zakiyatul Faizah, Supardi Supardi. Anat Cell Biol 2023;56:421-7. https://doi.org/10.5115/acb.23.056